BRAFV600E Overrides NOTCH Signaling in Thyroid Cancer

Volume: 31, Issue: 5, Pages: 787 - 799
Published: May 1, 2021
Abstract
Background: Several mechanisms likely cooperate with the mitogen-activated protein (MAP)-kinase pathway to promote cancer progression in the thyroid. One putative pathway is NOTCH signaling, which is implicated in several other malignancies. In thyroid cancer, data regarding the role of the NOTCH pathway are insufficient and even contradictory. Methods: A BRAFV600E-driven papillary thyroid carcinoma (PTC) mouse model was subjected to NOTCH...
Paper Details
Title
BRAFV600E Overrides NOTCH Signaling in Thyroid Cancer
Published Date
May 1, 2021
Journal
Volume
31
Issue
5
Pages
787 - 799
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.